| A. smeathmannii (Acridocarpus smeathmannii) | (AS) |
| Benign prostatic hyperplasia | (BPH) |
| Benzyl benzoate | (BB) |
| Concentrations inducing 50% of maximum agonist-induced contraction | (EC50) |
| Electrical field stimulation | (EFS) |
| Frequencies (f) inducing 50% of maximum EFS-induced contraction | (Ef50) |
| Gas chromatography–mass spectrometry | (GC-MS) |
| High-performance liquid chromatography | (HPLC) |
| Lower layer of A. smeathmannii | (HLASF) |
| Lower layer of A. smeathmannii fraction | (HLASFF12) (nBB) |
| Lower urinary tract symptoms | (LUTSs) |
| Maximum possible contractions | (Emax) |
| Negative logarithms of the molar concentration for agonists | (pEC50) |
| Noradrenaline | (NA) |
| Nuclear magnetic resonance | (NMR) |
| Phenylephrine | (PHE) |
| Radical prostatectomy | (rPx) |
| Retention factor | (Rf) |
| Thin layer chromatography | (TLC) |
| Homonuclear correlation spectroscopy | (COSY) |
| Nuclear Overhauser Effect Spectroscopy | (NOESY) |
| Heteronuclear single quantum coherence | (HSQC) |
| Distortionless Enhancement by Polarization Transfer | (DEPT) |
| Heteronuclear Multiple Bond Correlation | (HMBC) |